Insider proposes sale of 8,149 DTIL shares (NASDAQ: DTIL)

Rhea-AI Filing Summary

DTIL insider John A. Kelly filed a Form 144 reporting a proposed sale of 8,149 common shares that vested as restricted stock on 02/17/2026, handled through Fidelity Brokerage Services LLC. The filing also discloses a prior sale of 15,213 common shares on 01/21/2026.

Insights

Insider Transactions Analyst

Form 144 shows a proposed sale of 8,149 DTIL shares by John A. Kelly following restricted stock vesting.

The filing lists 8,149 common shares tied to restricted stock vesting on 02/17/2026 and handled via Fidelity Brokerage Services LLC. This is a disclosure of a proposed sale rather than an executed market transaction.

It also records a prior sale of 15,213 shares on 01/21/2026. Subsequent confirmations of execution or proceeds would appear in later filings.

FAQ

What did the DTIL Form 144 filed by John A. Kelly report?

The filing reports a proposed sale of 8,149 common shares that vested as restricted stock on 02/17/2026. It also notes a prior sale of 15,213 shares on 01/21/2026, with transactions routed through Fidelity.

How many DTIL shares vested for the insider on 02/17/2026?

The filing indicates 8,149 common shares vested as restricted stock on 02/17/2026. These vested shares are the quantity listed for the proposed sale in the Form 144 disclosure handled via Fidelity Brokerage Services LLC.

Did John A. Kelly sell DTIL shares recently before this Form 144?

Yes. The Form 144 records a sale of 15,213 common shares on 01/21/2026. That prior transaction is included in the filing’s "Securities Sold During The Past 3 Months" section alongside the proposed sale.

Through which broker will the proposed DTIL sale be executed?

The filing lists Fidelity Brokerage Services LLC at 900 Salem Street, Smithfield RI, as the broker-dealer associated with the proposed sale. The Form 144 ties the sale logistics to that brokerage for the disclosed shares.

Does the Form 144 confirm the sale was completed?

No. The Form 144 reports a proposed sale of 8,149 vested shares on 02/17/2026; it does not confirm execution. A subsequent filing would report completion or actual proceeds if the sale occurred.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/18/2026 - 04:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001590030
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PRECISION BIOSCIENCES INC
SEC File Number	001-38841
Address of Issuer	302 EAST PETTIGREW STREET SUITE A-100 DURHAM NORTH CAROLINA 27701
Phone	919-314-5512
Name of Person for Whose Account the Securities are To Be Sold	Kelly John Alexander
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	8149	31320.68	13256751	02/18/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/17/2026	Restricted Stock Vesting	Issuer			8149	02/17/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John A. Kelly 302 East Pettigrew St., Suite A-100 Durham NC 27701	Common	01/21/2026	15213	61259.71

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	02/18/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for John A. Kelly
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)